Aortic Atheromatous Lesions Developed in APA Hamsters with Streptozotocin induced Diabetes: A New Animal Model for Diabetic Atherosclerosis. 1. Histopathological Studies

Experimental Animals

Volumn 49, Issue 4, 2000, Pages 259-266

  Yamanouchi, Jun ^a   Nishida, Etsuko ^a   Itagaki, Shin Ichi ^a   Kawamura, Seiji ^a   Doi, Kunio ^a   Yoshikawa, Yasuhiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

APA hamster; Atheromatous lesion; Department of biomedical science; Diabetes; Graduate school of agricultural and life sciences; Macroangiopathy; University of tokyo

Indexed keywords

ANIMALIA; CRICETINAE;

ALLOXAN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL; AORTA DISEASE; ARTERIOSCLEROSIS; ARTICLE; BLOOD; DIABETIC ANGIOPATHY; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; HAMSTER; MALE; PATHOLOGY; TIME;

ALLOXAN; ANIMALS; AORTIC DISEASES; ARTERIOSCLEROSIS; CHOLESTEROL; CHOLESTEROL, HDL; CRICETINAE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DISEASE MODELS, ANIMAL; MALE; TIME FACTORS; TRIGLYCERIDES;

EID: 0034304285     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.49.259     Document Type: Article

References (45)

1. Bellosta, S., Mahley, R. W., Sanan, D. A., Murata, J., Newland, D. L., Taylor, J. M., and Pitas, R. E. 1995. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J. Clin. Invest. 96: 2170-2179.
2. Bishop, R. W. 1992. Structure of the hamster low density lipoprotein receptor gene. J. Lipid. Res. 33: 549-557.
3. Cotran, R. S., Kumar, V., and Robbins, S. L., eds. 1989. Robbins' Pathologic Basis of Disease, 4th ed. pp. 557-569, W.B. SAUNDERS COMPANY, Philadelphia.
4. Di, T. M., Sacco, R. L., Gersony, D., Nayak, H., Weslow, R. G., Kargman, D. E., and Homma, S. 1996. Aortic atheromas and acute ischemic stroke: A transesophageal echocardiographic study in an ethnically mixed population. Neurology 46: 1560-1566.
5. Diamond, J. R. 1991. Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int. Suppl. 31 : S29-S34.
6. Diamond, J. R. and Karnovsky, M. J. 1988. Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. Kidney Int. 33: 917-924.
7. Donahue, R.P. and Orchard, T.J. 1992. Diabetes mellitus and macrovascular complications. An epidemiological perspective. Diabetes Care 15: 1141-1155.
8. Fazio, S., Babaev, V.R., Murray, A.B., Hasty, A.H., Carter, K.J., Gleaves, L.A., Atkinson, J.B., and Linton, M.F. 1997. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc. Natl. Acad. Sci. U.S.A. 94: 4647-1652.
9. Gomez, C. R. 1990. Carotid plaque morphology and risk for stroke. Stroke 21: 148-151.
10. Goto, Y., Yamada, K., Ohyama, T., and Sato, K. 1990. Clinical studies on atherosclerosis in diabetics. Ann. N. Y. Acad. Sci. 598: 389-392.
11. Guyton, J.R. and Klemp, K.F. 1993. Transitional features in human atherosclerosis. Intimal thickening, cholesterol clefts, and cell loss in human aortic fatty streaks. Am. J. Pathol. 143: 1444-1457.
12. Han, J.S., Norimatsu, M., Sugawara, Y., and Doi, K. 1990. Acute toxicity of streptozotocin in Syrian hamsters of the APA strain. J. Toxicol. Pathol. 3: 189-199.
13. Han, J.S., Sugawara, Y., and Doi, K. 1992. Rapid induction of glomerular lipidosis in APA hamsters by streptozotocin. Int. J. Exp. Pathol. 73: 75-84.
14. Karalis, D.G., Chandrasekaran, K., Victor, M.F., Ross, J.J., and Mintz, G.S. 1991. Recognition and embolic potential of intraaortic atherosclerotic debris. J. Am. Coll. Cardiol. 17: 73-78.
15. Keane, W.F., Kasiske, B.L., and O'Donnell, M.P. 1988. Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis. Am. J. Nephrol. 8: 261-271.
16. Kowala, M.C., Rose, P.M., Stein, P.D., Goller, N., Recce, R., Beyer, S., Valentine, M., Barton, D., and Durham, S.K. 1995. Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol. Am. J. Pathol. 146: 819-826.
17. Kume, S., Takeya, M., Mori, T., Araki, N., Suzuki, H., Horiuchi, S., Kodama, T., Miyauchi, Y., and Takahashi, K. 1995. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am. J. Pathol. 147: 654-667.
18. Kunjathoor, V.V., Wilson, D.L., and LeBoeuf, R.C. 1996. Increased atherosclerosis in streptozotocin-induced diabetic mice. J. Clin. Invest. 97: 1769-1773.
19. Mendez, J.D. and Ramos, H.G. 1994. Animal models in diabetes research. Arch. Med. Res. 25: 367-375.
20. Milei, J., Parodi, J.C., Fernandez, A.G., Barone, A., Beigelman, R., Ferreira, L.M., Arrigoni, G., and Matturri, L. 1996. Carotid atherosclerosis. Immunocytochemical analysis of the vascular and cellular composition in endarterectomies. Cardiologia 41: 535-542.
21. Nagao, T., Sadoshima, S., Ibayashi, S., Takeya, Y., and Fujishima, M. 1994. Increase in extracranial atherosclerotic carotid lesions in patients with brain ishchemia in Japan. An angiographic study. Stroke 25: 766-770.
22. Nakamura, Y., Horii, Y., Nishino, T., Shiiki, H., Sakaguchi, Y., Kagoshima, T., Dohi, K., Makita, Z., Vlassara, H., and Bucala, R. 1993. Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am. J. Pathol. 143: 1649-1656.
23. Nathan, D.M. 1993. Long-term complications of diabetes mellitus. N. Engl. J. Med. 328: 1676-1685.
24. Nihoyannopoulos, P., Joshi, J., Athanasopoulos, G., and Oakley, C. M. 1993. Detection of atherosclerotic lesions in the aorta by transesophageal echocardiography. Am. J. Cardiol. 71: 1208-1212.
25. Nikkari, S.T., Solakivi, T., and Jaakkola, O. 1991. The hyperlipidemic hamster as an atherosclerosis model. Artery 18: 285-290.
26. Nishida, E., Yamanouchi, J., Ogata, S., Doi, K., and Itagaki, S. 1997. Modification of spontaneous renal lesion of APA hamsters by streptozotocin-induced diabetes. Int. J. Exp. Pathol. 78: 169-176.
27. Nistor, A., Bulla, A., Filip, D.A., and Radu, A. 1987. The hyperlipidemic hamster as a model of experimental atherosclerosis. Atherosclerosis 68: 159-173.
28. O'Brien, K.D., Deeb, S.S., Ferguson, M., McDonald, T.O., Allen, M.D., Alpers, C.E., and Chait, A. 1994. Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. Am. J. Pathol. 144: 538-548.
29. Okeda, T. 1996. Diabetes and atherosclerosis. Rinsho Byori 44: 1027-1030 (in Japanese with English summary).
30. Otto, J., Ordovas, J. M., Smith, D., van, D. D., Nicolosi, R. J., and Schaefer, E. J. 1995. Lovastatin inhibits diet induced atherosclerosis in F1B golden Syrian hamsters. Atherosclerosis 114: 19-28.
31. Peric, G.L. and Peric, G.M. 1983. Aortic and renal lesions in hypercholesterolemic adult, male, virgin sprague-dawley rats. Atherosclerosis 46: 57-65.
32. Rosenfeld, M.E., Butler, S., Ord, V.A., Lipton, B.A., Dyer, C.A., Curtiss, L.K., Palinski, W., and Witztum, J.L. 1993. Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesions. Arterioscler. Thromb. 13: 1382-1389.
33. Seaquist, E.R. 1998. Microvascular complications of diabetes. Strategies for managing retinopathy, nephropathy, and neuropathy. Postgrad. Med. 103: 61-63, 66-68.
34. Simionescu, M., Popov, D., Sima, A., Hasu, M., Costache, G., Faitar, S., Vulpanovici, A., Stancu, C., Stern, D., and Simionescu, N. 1996. Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model. The hyperlipemic-hyperglycemic hamster. Am. J. Pathol. 148: 997-1014.
35. Squadrito, G. and Cucinotta, D. 1991. The late complications of diabetes mellitus. Ann. Ital. Med. Int. 6: 126-136.
36. Stary, H.C., Chandler, A.B., and Dinsmore, R.E. 1995. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92: 1355-1374.
37. Stary, H.C., Chandler, A.B., and Glagov, S. 1994. A definition of initial fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 89: 2462-2478.
38. Steiner, G. 1985. Atherosclerosis, the major complication of diabetes. Adv. Exp. Med. Biol. 189: 277-297.
39. Sullivan, M.P., Cerda, J.J., Robbins, F.L., Burgin, C.W., and Beatty, R.J. 1993. The gerbil, hamster, and guinea pig as rodent models for hyperlipidemia. Lab. Anim. Sci. 43: 575-578.
40. Tajima, Y. 1968. Species and strains of experimental animals developed in Japan. Exp. Anim. 17: 27-39.
41. Toyoda, K., Yasaka, M., Nagata, S., and Yamaguchi, T. 1992. Aortogenic embolic stroke: a transesophageal echocardiographic approach. Stroke 23: 1056-1061.
42. Tunick, P. A., Perez, J. L., and Kronzon, I. 1991. Protruding atheromas in the thoracic aorta and systemic embolization. Ann. Intern. Med. 115: 423-427.
43. Vlassara, H. 1997. Recent progress in advanced glycation end products and diabetic complications. Diabetes 46: S19-S25.
44. Weinberger, J., Biscarra, V., Weisberg, M.K., and Jacobson, J.H. 1983. Factors contributing to stroke in patients with atherosclerotic disease of the great vessels: The role of diabetes. Stroke 14: 709-712.
45. Wu, J. T. 1993. Advanced glycosylation end products: a new disease marker for diabetes and aging. J. Clin. Lab. Anal. 7: 252-255.